A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19)

被引:11
作者
Bahranifard, Bahar [1 ]
Mehdizadeh, Somayeh [2 ]
Hamidi, Ali [3 ]
Khosravi, Alireza [4 ]
Emami, Ramin [5 ]
Mirzaei, Kamran [6 ]
Nemati, Reza [1 ]
Nemati, Fatemeh [7 ]
Assadi, Majid [8 ]
Gholamrezanezhad, Ali [9 ]
机构
[1] Bushehr Univ Med Sci, Dept Neurol, Bushehr, Iran
[2] Bushehr Univ Med Sci, Dept Pathol, Bushehr, Iran
[3] Bushehr Univ Med Sci, Dept Med Lib & Informat Sci, Bushehr, Iran
[4] Zahedan Univ Med Sci, Dept Neurol, Zahedan, Iran
[5] Abhar Med Clin, Dept Neurol, Abhar, Iran
[6] Bushehr Univ Med Sci, Dept Community Med, Bushehr, Iran
[7] Persian Gulf Univ, Dept English Language & Literature, Bushehr, Iran
[8] Persian Gulf Nucl Med Res Ctr, Dept Mol Imaging & Radionuclide Therapy MIRT, Bushehr, Iran
[9] Univ Southern Calif USC, Keck Sch Med, Los Angeles, CA USA
关键词
Neuroradiological; computed tomography; magnetic resonance; COVID-19; brain; spinal; IMAGING FINDINGS; OUTCOMES;
D O I
10.1177/19714009211029177
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection. Methods The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text articles published from 23 January 2020 to 23 February 2021. Results In 23 studies the number of patients with SARS-CoV-2 infection was 20,850 and the number of patients with neurological manifestations was 1996 (9.5%). The total number of patients with neuroradiological abnormalities was 602 (2.8%). SARS-CoV-2 has led to various neuroimaging abnormalities which can be categorised by neuroanatomical localisation of lesions and their main probable underlying pathogenesis. Cranial nerve and spinal root abnormalities were cranial neuritis and polyradiculitis. Parenchymal abnormalities fell into four groups of: (a) thrombosis disorders, namely ischaemic stroke and sinus venous thrombosis; (b) endothelial dysfunction and damage disorders manifested as various types of intracranial haemorrhage and posterior reversible encephalopathy syndrome; (c) hypoxia/hypoperfusion disorders of leukoencephalopathy and watershed infarction; and (d) inflammatory disorders encompassing demyelinating disorders, encephalitis, vasculitis-like disorders, vasculopathy and cytotoxic lesions of the corpus callosum. Leptomeninges disorders included meningitis. Ischaemic stroke was the most frequent abnormality in these studies. Conclusion The review study suggests that an anatomical approach to the classification of heterogeneous neuroimaging findings in patients with SARS-CoV-2 and neurological manifestations would lend itself well for use by practitioners in diagnosis and treatment planning.
引用
收藏
页码:3 / 24
页数:22
相关论文
共 50 条
[21]   Parenchymal lung changes on CT in patients with coronavirus disease 2019 (COVID-19) [J].
Halldorsson, Arnljotur Bjorn ;
Axelsson, Gisli Thor ;
Jonsson, Helgi Mar ;
Isaksson, Johann David ;
Hardardottir, Hronn ;
Gudmundsson, Gunnar ;
Hansdottir, Sif .
LAEKNABLADID, 2021, 107 (10) :460-468
[22]   Differences of the Chest Images Between Coronavirus Disease 2019 (COVID-19) Patients and Influenza Patients: A Systematic Review and Meta-analysis [J].
Han, Yingying ;
Wang, Zhijia ;
Li, Xingzhao ;
Zhong, Zhuan .
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2025, 22 (03) :641-650
[23]   The management of coronavirus disease 2019 (COVID-19) [J].
Liu, Jialin ;
Liu, Siru .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) :1484-1490
[24]   Resolution of coronavirus disease 2019 (COVID-19) [J].
Habas, Khaled ;
Nganwuchu, Chioma ;
Shahzad, Fanila ;
Gopalan, Rajendran ;
Haque, Mainul ;
Rahman, Sayeeda ;
Majumder, Anwarul Azim ;
Nasim, Talat .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (12) :1201-1211
[25]   The Coronavirus Disease 2019 (COVID-19) Pandemic [J].
Baloch, Saira ;
Baloch, Mohsin Ali ;
Zheng, Tianli ;
Pei, Xiaofang .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 250 (04) :271-278
[26]   Spectrum of Immunopathogenesis in Coronavirus Disease 2019 (COVID-19): An Updated Review [J].
El-Khawanky, Mohamed M. ;
Saleh, Mohamed A. ;
Oruch, Ramadhan ;
Attia, Gouda H. .
INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2021, 17 (06) :358-369
[27]   Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Review of the Current Knowledge [J].
Ghamri, Kholoud Alawi .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2022, 11 (02) :92-99
[28]   Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence [J].
Hui Xian Jaime Lin ;
Sanda Cho ;
Veeraraghavan Meyyur Aravamudan ;
Hnin Yu Sanda ;
Raj Palraj ;
James S. Molton ;
Indumathi Venkatachalam .
Infection, 2021, 49 :401-410
[29]   Drug repurposing against coronavirus disease 2019 (COVID-19): A review [J].
Luo, Lianxiang ;
Qiu, Qin ;
Huang, Fangfang ;
Liu, Kaifeng ;
Lan, Yongqi ;
Li, Xiaoling ;
Huang, Yuge ;
Cui, Liao ;
Luo, Hui .
JOURNAL OF PHARMACEUTICAL ANALYSIS, 2021, 11 (06) :683-690
[30]   Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence [J].
Lin, Hui Xian Jaime ;
Cho, Sanda ;
Meyyur Aravamudan, Veeraraghavan ;
Sanda, Hnin Yu ;
Palraj, Raj ;
Molton, James S. ;
Venkatachalam, Indumathi .
INFECTION, 2021, 49 (03) :401-410